Syon Capital »

Regeneron Pharmaceuticals shares owned by Syon Capital

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Syon Capital from 13F filings

Historical chart of Syon Capital investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Syon Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Syon Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $856k 889 962.49
2023-12-31 $687k 782 878.29
2023-09-30 $505k 614 822.96

More positions owned by Syon Capital

Spdr Portfolio Aggregate Bond Etf Etf (SPAB)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Ishares Core International Aggregate Bond Etf Etf (IAGG)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)
Invesco Emerging Markets Sovereign Debt Etf Etf (PCY)
Microsoft Corp Stock (MSFT)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Invesco China Technology Etf Etf (CQQQ)
Ishares Gold Trust Etf (IAU)
Ishares Msci China Etf Etf (MCHI)
Vanguard Dividend Appreciation Etf Etf (VIG)

View all positions for Syon Capital

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals